Moderate-to-severe early-onset hyperuricaemia: A prognostic marker of long-term kidney transplant outcome

Nephrology Dialysis Transplantation

Volumn 24, Issue 8, 2009, Pages 2584-2590

  Min, Sang Il ^a   Yun, Ik Jin ^b   Kang, Jin Mo ^c   Park, Yang Jin ^a   Min, Seung Kee ^a   Ahn, Curie ^a   Kim, Sang Joon ^a   Ha, Jongwon ^a  

^a Seoul National University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Gachon University College of Medicine   (South Korea)

Author keywords

Chronic allograft nephropathy; Graft function; Graft survival; Hyperuricaemia; Renal transplantation

Indexed keywords

URIC ACID;

ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT SURVIVAL; HUMAN; HYPERURICEMIA; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE OF ONSET; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERURICEMIA; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PROGNOSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; URIC ACID;

EID: 67651122980     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp192     Document Type: Article

References (25)

1. Clive DM. Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol 2000; 11: 974-979
2. Mazzali M. Uric acid and transplantation. Semin Nephrol 2005; 25: 50-55
3. Perico N, Codreanu I, Caruso M et al. Hyperuricemia in kidney transplantation. Contrib Nephrol 2005; 147: 124-131
4. Lin HY, Rocher LL, McQuillan MA et al. Cyclosporine-induced hyperuricemia and gout. N Engl J Med 1989; 321: 287-292
5. Iseki K, Ikemiya Y, Inoue T et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004; 44: 642-650
6. Kang DH, Nakagawa T. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. Semin Nephrol 2005; 25: 43-49
7. Talaat KM, el-Sheikh AR. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol 2007; 27: 435-440
8. Nakagawa T, Mazzali M, Kang DH et al. Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol 2003; 23: 2 - 7
9. Mazzali M, Kanellis J, Han L et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002; 282: F991-F997
10. Johnson RJ, Kang DH, Feig D et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190
11. Gores PF, Fryd DS, Sutherland DE et al. Hyperuricemia after renal transplantation. Am J Surg 1988; 156: 397-400
12. Armstrong KA, Johnson DW, Campbell SB et al. Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients? Transplantation 2005; 80: 1565 - 1571
13. Akgul A, Bilgic A, Ibis A et al. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients? Transplant Proc 2007; 39: 1023-1026
14. Gerhardt U, Grosse Huttmann M, Hohage H. Influence of hy-perglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients. Clin Transplant 1999; 13: 375 - 379
15. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723
16. Levey AS, Bosch JP, Lewis JB et al. (Modification of Diet in Renal Disease Study Group). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
17. Johnson RJ, Rideout BA. Uric acid and diet - insights into the epidemic of cardiovascular disease. N Engl J Med 2004; 350: 1071 - 1073
18. Lee MJ, Popkin BM, Kim S. The unique aspects of the nutrition transition in South Korea: the retention of healthful elements in their traditional diet. Public Health Nutr 2002; 5: 197-203
19. Kanbay M, Akcay A, Huddam B et al. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Transplant Proc 2005; 37: 3119-3120
20. Pilmore HL, Faire B, Dittmer I. Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature. Transplantation 2001; 72: 1703-1705
21. Kang DH, Nakagawa T, Feng L et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002; 13: 2888-2897
22. Siu YP, Leung KT, Tong MK et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006; 47: 51-59
23. Perez-Ruiz F, Gomez-Ullate P, Amenabar JJ et al. Long-term efficacy of hyperuricaemia treatment in renal transplant patients. Nephrol Dial Transplant 2003; 18:603-606
24. Zurcher RM, Bock HA, Thiel G. Hyperuricaemia in cyclosporin-treated patients: GFR-related effect. Nephrol Dial Transplant 1996; 11:153-158
25. Harambat J, Dubourg L, Ranchin B et al. Hyperuricemia after liver transplantation in children. Pediatr Transplant 2008; 12: 847 - 853